mBIOTA Labs Announces Results from First Prospective Clinical Trial of Novel, Palatable Elemental Diet in Patients with SIBO and IMO
2024年5月20日 - 8:14PM
ビジネスワイヤ(英語)
mBIOTA Elemental™ clinical trial achieves first
perfect compliance rate for an orally-ingested elemental
diet
mBIOTA Labs, a medical food company revolutionizing oral
nutrition through their proprietary palatable elemental diet,
mBIOTA Elemental™, today announced the initial study results of
their first prospective clinical trial assessing the efficacy of
the mBIOTA Elemental™ diet in patients with small intestinal
bacterial overgrowth (SIBO), intestinal methanogen overgrowth
(IMO), or a combination of the two.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240520439461/en/
mBIOTA prospective clinical trial:
clinical eradication rates of SIBO and/or IMO by patient cohort,
based on normalization of patient's lactulose breath test after day
14 of exclusive elemental diet (Graphic: Business Wire)
Presented in an abstract at Digestive Disease Week 2024, data
from the trial revealed 100% of SIBO-only participating patients
completely eradicated their SIBO after completing the two-week
course of orally-ingested mBIOTA Elemental™ and 73% of patients
eradicated their SIBO/IMO overall. Notably, participants achieved a
groundbreaking 100% compliance rate, with all patients successfully
completing the two-week course of the mBIOTA Elemental™ diet. The
trial was conducted in November 2023 at Cedars-Sinai Medical Center
in Los Angeles, California.
“These exciting results exceeded our expectations and offer hope
to the millions of SIBO and IMO patients who have previously
struggled to complete an elemental diet or discounted this highly
effective treatment entirely due to lack of awareness or hesitation
regarding its palatability,” says Nicola Wodlinger, CEO of mBIOTA
Labs. “With mBIOTA Elemental™, we are prioritizing the patient
experience without sacrificing efficacy and, as indicated in the
results of our first clinical trial, creating an incredible
opportunity for gastroenterologists to help patients manage GI
dysfunction. We hope to help more and more patients and providers
experience the benefits of the mBIOTA Elemental™ diet and expand
its clinical applications in the coming years.”
For more than 50 years and across hundreds of clinical studies,
doctors and scientists have demonstrated the clinical effectiveness
of elemental diets for the management of a wide range of
gastrointestinal diseases. However, due to the traditionally
unpalatable taste of elemental diets, they are infrequently used as
patient compliance is challenging. The introduction of mBIOTA’s
truly palatable elemental diet this year now offers patients an
approachable and clinically reliable option to manage GI disorders
like SIBO and IMO.
To learn more about mBIOTA Labs and mBIOTA Elemental™, visit
www.mbiotaelemental.com.
About mBIOTA Labs mBIOTA Labs
specializes in the development of medical foods for
gastrointestinal (GI) dysfunction. mBIOTA Labs is revolutionizing
oral nutrition with their proprietary product, mBIOTA Elemental™
diet, a medical food designed to address the historic issues with
elemental diets: poor taste and patient compliance. Developed in
partnership with leading gastroenterologists and food scientists
for the dietary management of GI dysfunction, including small
intestinal bacterial overgrowth (SIBO), irritable bowel syndrome
(IBS), and other conditions, the highly palatable mBIOTA Elemental™
diet delivers essential nutrients, vitamins and minerals in a
readily absorbable formula. For more information on mBIOTA Labs and
mBIOTA Elemental™, visit www.mbiotaelemental.com.
About DDW Digestive Disease Week®
(DDW) is the largest international gathering of physicians,
researchers and academics in the fields of gastroenterology,
hepatology, endoscopy and gastrointestinal surgery. Jointly
sponsored by the American Association for the Study of Liver
Diseases (AASLD), the American Gastroenterological Association
(AGA), the American Society for Gastrointestinal Endoscopy (ASGE)
and the Society for Surgery of the Alimentary Tract (SSAT), DDW is
an in-person and online meeting from May 18-21, 2024. The meeting
showcases more than 4,400 abstracts and hundreds of lectures on the
latest advances in GI research, medicine and technology. More
information can be found at www.ddw.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240520439461/en/
Media Contact for mBIOTA Labs: Matter Communications
mbiota@matternow.com